Cardiovascular disease is a leading cause of global mortality, accounting for almost 17
million deaths annually or 30% of all global mortality. In developing countries, it causes …

PURPOSE: To define the practical clinical guidelines that can be implemented by busy
radiation oncology departments to minimize the risk of harm to patients with implanted …

Aims Risk stratification algorithms for sudden cardiac death (SCD) in hypertrophic
cardiomyopathy (HCM) and regional differences in clinical practice have evolved over time …

Sudden cardiac death is a major public health problem affecting 500,000 patients annually
in the United States alone. The major risk factor for sudden cardiac death is the presence of …

Reuse of medical device is accepted worldwide. Benefits of reuse include not only cost
saving but a favorable impact on environment. However, certain requirements should be met …

Background In recent years, indications for cardiac implantable electrical devices (CIEDs)
have broadened; however, budget constraints can significantly impact patient access to …

Abstract Background and Aims Implantable cardioverter-defibrillators (ICDs) are critical for
preventing sudden cardiac death (SCD) in arrhythmogenic right ventricular cardiomyopathy …

Background: Device acceptance may comprise one of the keys to identifying implantable
cardioverter defibrillator (ICD) patients at risk for adverse health outcomes in clinical …

The implantable cardioverter defibrillator (ICD) is the treatment of choice for life‐threatening
arrhythmias, with ICD indications having recently been extended to include primary …

Context: The rate of ICD implantation of has grown substantially after results of primary and
secondary prevention trials have demonstrated mortality superiority over pharmacologic …